Abstract
No public abstract is available from the verified source records.
Mikaela E. Gill, Aditi Jogdand, Caroline Schissel, Mei-Sing Ong, Sara Barmettler, Jocelyn R. Farmer
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Diagnostic criteria for common variable immunodeficiency disorders
10.1016/j.jaip.2016.02.023 · 2016
State-of-the-art diagnostic evaluation of common variable immunodeficiency
10.1016/j.anai.2021.03.005 · 2021
The European Society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity
10.1016/j.jaip.2019.02.004 · 2019
International Consensus document (ICON): common variable immunodeficiency disorders
10.1016/j.jaip.2015.07.025 · 2016
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions
10.1111/j.1365-2141.2009.07669.x · 2009
Primary immunodeficiency diseases in Australia and New Zealand
10.1007/s10875-007-9105-z · 2007
Global distribution of common variable immunodeficiency (CVID) in the light of the UNDP human development index (HDI): a preliminary perspective of a rare disease
10.1155/2020/8416124 · 2020
Morbidity and mortality in common variable immune deficiency over 4 decades
10.1182/blood-2011-09-377945 · 2012
Identification and characterization of a nationwide danish adult common variable immunodeficiency cohort
datacite
Confidence 0%
10.1111/sji.12551 · 2017
Gastrointestinal manifestations of common variable immunodeficiency: a mentored review
10.1007/s10620-025-09106-8 · 2025
A systematic literature review of CVID reveals pervasive detrimental noninfectious manifestations
10.70962/jhi.20250157 · 2026
Malignancy in common variable immunodeficiency: a systematic review and meta-analysis
10.1080/1744666x.2019.1658523 · 2019
Common variable immunodeficiency disorders: division into distinct clinical phenotypes
10.1182/blood-2007-11-124545 · 2008
Common variable immunodeficiency and autoimmune diseases: a 10-year single-center experience
10.46497/archrheumatol.2024.10729 · 2024
A cross-sectional study of health-related quality of life in patients with predominantly antibody deficiency
10.1007/s10875-024-01781-y · 2024
Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden
10.1016/j.clim.2022.108931 · 2022
Unresolved referenced work
Kept as external metadata until matched
Economic burden of common variable immunodeficiency: annual cost of disease
10.1586/1744666x.2015.1029457 · 2015
Common variable immunodeficiency: more pathways than roads to rome
10.1146/annurev-pathmechdis-031521-024229 · 2023
Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review
10.1186/s13223-022-00661-7 · 2022
Uncovering risk factors of premature mortality in common variable immunodeficiency
10.1016/j.jaip.2025.03.009 · 2025
Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study
10.1007/s10875-011-9511-0 · 2011
Unresolved referenced work
Kept as external metadata until matched
10.3389/fimmu.2017.01740
10.3389/fimmu.2017.01740
Memory B cells in common variable immunodeficiency: clinical associations and sex differences
10.1016/j.clim.2008.02.013 · 2008
T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections
10.1111/j.1365-2249.2012.04643.x · 2012
B-Cell and T-Cell phenotypes in CVID patients correlate with the clinical phenotype of the disease
10.1007/s10875-010-9424-3 · 2010
Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect
10.1086/606059 · 2009
Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells
10.1073/pnas.0901984106 · 2009
Loss of B cell tolerance at the T2/T3a B cell transition is a convergent pathogenic mechanism in common variable immunodeficiency
2025
Unresolved referenced work
Kept as external metadata until matched
Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation
10.1016/j.jaut.2023.103088 · 2023
A decreased frequency of regulatory T cells in patients with common variable immunodeficiency
10.1371/journal.pone.0006269 · 2009
Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease
10.1016/j.clim.2008.12.006 · 2009
Functions of tfh cells in common variable immunodeficiency
10.3389/fimmu.2020.00006 · 2020
Utility of serum cytokine testing to differentiate complicated common variable immunodeficiency in resource limited settings
2025
BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency
10.1172/jci.insight.122728 · 2019
Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients
10.3389/fimmu.2023.1268207 · 2023
Targeted proteomics reveals inflammatory pathways that classify immune dysregulation in common variable immunodeficiency
10.1007/s10875-020-00908-1 · 2021
Soluble interleukin-2 receptor is a promising serum biomarker for granulomatous disease in common variable immune deficiency
10.1007/s10875-020-00947-8 · 2021
Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficiencies
10.1038/s43856-023-00412-8 · doi-reference
A predictive model for identification of pediatric individuals with common variable immunodeficiency through electronic medical records
10.1016/j.jaci.2025.02.032 · doi-reference
Electronic health record signatures identify undiagnosed patients with common variable immunodeficiency disease
10.1126/scitranslmed.ade4510 · doi-reference
10.3389/fimmu.2017.00678
10.3389/fimmu.2017.00678 · doi-reference
Primary immunodeficiencies in a mesoregion of São Paulo, Brazil: Epidemiologic, clinical, and geospatial approach
10.3389/fimmu.2020.00862 · doi-reference
Clinical disparity of primary antibody deficiency patients at a safety net hospital
10.1016/j.jaip.2021.03.021 · doi-reference
Racial and ethnic disparities in early mortality among patients with inborn errors of immunity
10.1016/j.jaci.2023.09.036 · doi-reference
Experiences with diagnostic delay among underserved racial and ethnic patients: a systematic review of the qualitative literature
10.1136/bmjqs-2024-017506 · doi-reference
Telehealth and allergy services in rural and regional locations that lack specialty services
10.1016/j.jaip.2022.06.025 · doi-reference
Access to specialty healthcare in urban versus rural US populations: a systematic literature review
10.1186/s12913-019-4815-5 · doi-reference
Rural health disparities in allergy, asthma, and immunologic diseases: the current state and future direction for clinical care and research
10.1016/j.jaip.2023.11.030 · doi-reference
The status of US allergy/immunology physicians in the 21st century: a report from the American Academy of Allergy, Asthma & Immunology Workforce Committee
10.1016/j.jaci.2007.01.040 · doi-reference
Principles supporting dynamic clinical care teams: an American College of Physicians position paper
10.7326/0003-4819-159-9-201311050-00710 · doi-reference
Nurse practitioners and physician assistants: an underestimated workforce for older adults with cancer
10.1111/jgs.15931 · doi-reference
Role of advanced practice providers in the cardiac intensive care unit team
10.1016/j.jacc.2023.08.061 · doi-reference
Revealing disease subtypes and heterogeneity in common variable immunodeficiency through transcriptomic analysis
10.1038/s41598-024-74728-3 · doi-reference
CVID enteropathy associated with chronic norovirus infection: background, clinical features, and therapeutic aspects
10.1002/rmv.70081 · doi-reference
The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency
10.1038/ajg.2014.432 · doi-reference
Autoimmunity and inflammation in CVID: a possible crosstalk between immune activation, gut microbiota, and epigenetic modifications
10.1007/s10875-018-0574-z · doi-reference
Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency
10.1016/j.jaci.2012.02.011 · doi-reference
Splenomegaly in CVID patients associates with CMV replication and alterations of immune cells and functions
10.1016/j.imlet.2025.107058 · doi-reference
Cytomegalovirus drives Vδ1+ γδ T cell expansion and clonality in common variable immunodeficiency
10.1038/s41467-024-48527-3 · doi-reference
Histocompatibility complex status and mendelian randomization analysis in unsolved antibody deficiency
10.3389/fimmu.2020.00014 · doi-reference
Genome-wide association identifies diverse causes of common variable immunodeficiency
10.1016/j.jaci.2011.02.039 · doi-reference
Systematic benchmark of state-of-the-art variant calling pipelines identifies major factors affecting accuracy of coding sequence variant discovery
10.1186/s12864-022-08365-3 · doi-reference
Plasma protein profiling reflects T(H)1-driven immune dysregulation in common variable immunodeficiency
10.1016/j.jaci.2020.01.046 · doi-reference
Role of B cell activating factor in CVID lung disease
10.1016/j.jaci.2015.12.722 · doi-reference
Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications
10.1016/j.jaci.2021.06.008 · doi-reference
Expansion of a distinct cytotoxic CD4 TFH-cell cluster in lymph nodes of patients with complicated common variable immunodeficiency
10.1016/j.jaci.2025.09.032 · doi-reference
T-bethighCD21low B cells: the need to unify our understanding of a distinct B cell population in health and disease
10.1016/j.coi.2023.102300 · doi-reference
The EUROclass trial: defining subgroups in common variable immunodeficiency
10.1182/blood-2007-06-091744 · doi-reference
Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects
10.1023/a:1025373601374 · doi-reference
Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease
10.1182/blood.v99.5.1544 · doi-reference
Hepatic manifestations in common variable immunodeficiency associated with mortality and worse Hospital outcomes in nationwide analysis using national readmission database
10.1016/j.jaip.2025.09.021 · doi-reference
Interim analysis: open-label extension study of leniolisib for patients with APDS
10.1016/j.jaci.2023.09.032 · doi-reference
Abatacept restores dysregulated transcriptomic and proteomic profile in disorders of CTLA-4 insufficiency
10.1016/j.jaci.2025.08.027 · doi-reference
Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4
10.1016/j.jaci.2015.08.036 · doi-reference
Mechanism-based strategies for the management of autoimmunity and immune dysregulation in primary immunodeficiencies
10.1016/j.jaip.2016.08.004 · doi-reference
Treatment strategies for GLILD in common variable immunodeficiency: a systematic review
10.3389/fimmu.2021.606099 · doi-reference
CVID enteropathy is difficult to treat and shows a heterogeneous histopathology
10.1007/s10875-025-01920-z · doi-reference